A signaling molecule can support a process, but it cannot override poor sleep, undertraining, or an injury that needs rest and rehab
Human anecdotal reports describe early symptom improvement at 1 to 2 weeks and more complete repair outcomes at 4 to 8 weeks
Flynn McGuire at the University of Utah, for example, said: The amount of hype to evidence is so skewed, its crazy, and that BPC-157 Should not be used by humans. At the same time, other physicians and researchers see things differently, and are prescribing BPC-157 for a wide variety of illnesses and injuries: ulcerative colitis, orthopedic injuries, and even mental health
Some peptide therapies are FDA-approved for certain conditions
Vitamin B12 is also known as cobalamin
Weeks 3 to 4 First real texture shifts appear